Kemadrin

Active Ingredient(s): Procyclidine
FDA Approved: * July 27, 1955
Pharm Company: * MONARCH PHARMS
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Kemadrin Overview

Procyclidine is an anticholinergic drug principally used for the treatment of drug-induced parkinsonism, akathisia and acute dystonia; Parkinson disease; and idiopathic or secondary dystonia. Contents 1 Uses 2 Overdose 3 Synthesis 4 See also 5 References 6 Further reading Uses It is used in patients with parkinsonism and akathisia, and to reduce the side effects of antipsychotic treatment given for schizophrenia. Procyclidine is also a second-line drug for the treatment of Parkinso...

Read more Kemadrin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Procyclidine

Recent Kemadrin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Procyclidine
  • Tablet: 2mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Procyclidine or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA